Medical Condition News

RSS

Testing athletes for concussions may induce mental fatigue

Testing athletes for concussions may induce mental fatigue in subjects whether or not they have a head injury, according to Penn State researchers.

7 Dec 2011

TAU develops tumor destruction method that also creates immunity

Even when surgical tumor removal is combined with a heavy dose of chemotherapy or radiation, there's no guarantee that the cancer will not return. Now researchers at Tel Aviv University are strengthening the odds in favor of permanent tumor destruction - and an immunity to the cancer's return - with a new method of tumor removal.

7 Dec 2011

Milk powder outperforms lower-dose therapy for treatment of food allergies

A small study by researchers at the Johns Hopkins Children's Center and Duke University shows that eating higher doses of milk protein in the form of dry powder substantially outperforms lower-dose therapy — a few drops of liquid milk extract under the tongue — for treatment of food allergies.

7 Dec 2011

Purdue, GE Healthcare and Notre Dame announce commercial availability of Veo CT scan

Demonstrating their shared legacy of innovative research and commitment to patient-centered medical technology, the University of Notre Dame, Purdue University and GE Healthcare have announced the commercial availability of a new CT scanning technology, called Veo-, that enables physicians to diagnose patients with high clarity images at previously-unattainable low radiation dose levels.

7 Dec 2011

Researchers discover new tick-borne infection

Researchers at the University of Gothenburg's Sahlgrenska Academy have discovered a brand new tick-borne infection. Since the discovery, eight cases have been described around the world, three of them in the Gothenburg area, Sweden.

7 Dec 2011

INT-777 shows promise against metabolic syndrome

Heart disease is a major cause of death in industrialised countries, and is strongly associated with obesity and diabetes. Many scientists believe that what links these conditions is a chronic, low-grade inflammation.

7 Dec 2011

Circadian activity rhythm linked to subsequent development of dementia or MCI

Older women with weaker circadian rhythms, who are less physically active or are more active later in the day are more likely to develop dementia or mild cognitive impairment than women who have a more robust circadian rhythm or are more physically active earlier in the day. That's the finding of a new study in the latest issue of the Annals of Neurology.

7 Dec 2011

Report shows how mutant gene influences lipid metabolism

People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way.

7 Dec 2011

Obese, overweight people at increased risk of cancer

More than a quarter of obese and overweight people do not want to lose weight and many more are unaware of the benefits brought by a healthy lifestyle, a new survey by Cancer Research UK reveals..

7 Dec 2011

Smoking, excess weight, unhealthy diets and alcohol cause cancer

More than 100,000 cancers - equivalent to one third of all those diagnosed in the UK each year - are being caused by smoking, unhealthy diets, alcohol and excess weight, according to new research by Cancer Research UK.

7 Dec 2011

$Study: Dental x-rays can investigate bone structure and predict fractures$

Study: Dental x-rays can investigate bone structure and predict fractures

It is now possible to use dental X-rays to predict who is at risk of fractures, reveals a new study from researchers at the Sahlgrenska Academy reported in the journal Nature Reviews Endocrinology.

6 Dec 2011

Fatty livers burn more fat, not less

When our livers become loaded with fat, it isn't because they are slacking. A new study of human patients in the December Cell Metabolism shows that fatty livers actually burn more fat, not less. All that "hard work" may be at the root of the organ damage that comes with nonalcoholic fatty liver disease (NAFLD), a condition associated with insulin resistance that affects about one in three in the U.S. population.

6 Dec 2011

Study evaluates whether genetic GST polymorphisms increase risk of ALD in alcoholics

It has been widely observed that only a small percentage of alcoholics develop cirrhosis of the liver, the most advanced form of alcoholic liver disease (ALD); the reason why all alcoholics do not develop such disease is not known. The present study from Spain, that includes original work and a meta-analysis, evaluates whether genetic polymorphisms that determine levels of glutathione-S-transferases (GST) relate to the risk of developing ALD among alcoholics.

6 Dec 2011

Low vaccination rate for flu vaccines in diabetic patients

"The vaccination rate for flu vaccines in diabetic patients in Austria is unfortunately particularly low," says study leader Thomas Dorner from the Institute of Social Medicine (Public Health Centre) at the Medical University of Vienna. An "unsettling gender difference" has also been noted, with men in this case taking the lead: 39 per cent of male diabetics are vaccinated against flu, whereas only 30 per cent of female diabetics are.

6 Dec 2011

Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S.

Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., has launched an authorized generic version of Caduet in the U.S. market, as part of an agreement with Pfizer Inc.

6 Dec 2011

Therakos commences enrollment in photopheresis Phase IIb clinical study for chronic GvHD

Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).

6 Dec 2011

Positive final results from BioLineRx BL-1021 Phase Ia study for neuropathic pain

BioLineRx announced today the final results of the Phase Ia study of BL-1021, an orally available small molecule for neuropathic pain.

6 Dec 2011

PDUFA goal date of NDA for Protalix's taliglucerase alfa extended

Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.

6 Dec 2011

Alzheimer's Australia, Bupa Health launch brain health app in the UK

The Bupa Health Foundation and Alzheimer's Australia have announced the UK launch of a world-first brain health app, the latest digital tool to help in the fight against dementia.

6 Dec 2011

Biosensors can detect oxidant production in living organism

Arterial calcification and coronary heart disease, neurodegenerative diseases such as Parkinson's and Alzheimer's, cancer and even the aging process itself are suspected to be partially caused or accelerated by oxidative stress. Oxidative stress arises in tissues when there is an excess of what are called reactive oxygen species.

6 Dec 2011